Carline T.

Carline T. is an Evaluator in Pharmacovigilance specializing in gene therapy, contrast products, and radiopharmaceuticals at ANSM since 2022. After a decade as a non-clinical toxicologist at Anses, Carline completed a university diploma in pharmacovigilance from the University of Paris. Previously, Carline held roles in regulatory affairs and scientific project management, contributing to the development and evaluation of REACH-CLP dossiers. Their educational background includes a Doctorate in Pharmacy and a Master’s in non-clinical R&D from the University of Montpellier.